Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Liabilities and Shareholders Equity (2022 - 2023)

Bluejay Diagnostics' Liabilities and Shareholders Equity history spans 2 years, with the latest figure at $8.2 million for Q3 2023.

  • For Q3 2023, Liabilities and Shareholders Equity fell 47.49% year-over-year to $8.2 million; the TTM value through Dec 2023 reached $27.6 million, down 59.02%, while the annual FY2022 figure was $13.5 million, N/A changed from the prior year.
  • Liabilities and Shareholders Equity for Q3 2023 was $8.2 million at Bluejay Diagnostics, down from $8.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $20.1 million in Q1 2022 and bottomed at $8.2 million in Q3 2023.